Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Resveratrol in Breast Cancer Treatment: From Cellular Effects to Molecular Mechanisms of Action Publisher Pubmed



Behroozaghdam M1, 2 ; Dehghani M2 ; Zabolian A3 ; Kamali D4 ; Javanshir S5 ; Hasani Sadi F6 ; Hashemi M2 ; Tabari T7 ; Rashidi M8, 9 ; Mirzaei S10 ; Zarepour A11 ; Zarrabi A11 ; De Greef D12 ; Bishayee A12
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, 1983969411, Iran
  2. 2. Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, 193951495, Iran
  3. 3. Department of Orthopedics, School of Medicine, 5th Azar Hospital, Golestan University of Medical Sciences, Golestan, 4913815739, Iran
  4. 4. School of Medicine, Tehran University of Medical Sciences, Tehran, 141556559, Iran
  5. 5. School of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, 193951495, Iran
  6. 6. School of Medicine, Kerman University of Medical Sciences, Kerman, 7616913555, Iran
  7. 7. Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, 1417935840, Iran
  8. 8. Department Pharmacology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, 4815733971, Iran
  9. 9. The Health of Plant and Livestock Products Research Center, Mazandaran University of Medical Sciences, Sari, 4815733971, Iran
  10. 10. Department of Biology, Faculty of Science, Islamic Azad University, Science and Research Branch, Tehran, 1477893855, Iran
  11. 11. Department of Biomedical Engineering, Faculty of Engineering and Natural Sciences, Istinye University, Istanbul, 34396, Turkey
  12. 12. College of Osteopathic Medicine, Lake Erie College of Osteopathic Medicine, Bradenton, 34211, FL, United States

Source: Cellular and Molecular Life Sciences Published:2022


Abstract

Breast cancer (BC) is one of the most common cancers in females and is responsible for the highest cancer-related deaths following lung cancer. The complex tumor microenvironment and the aggressive behavior, heterogenous nature, high proliferation rate, and ability to resist treatment are the most well-known features of BC. Accordingly, it is critical to find an effective therapeutic agent to overcome these deleterious features of BC. Resveratrol (RES) is a polyphenol and can be found in common foods, such as pistachios, peanuts, bilberries, blueberries, and grapes. It has been used as a therapeutic agent for various diseases, such as diabetes, cardiovascular diseases, inflammation, and cancer. The anticancer mechanisms of RES in regard to breast cancer include the inhibition of cell proliferation, and reduction of cell viability, invasion, and metastasis. In addition, the synergistic effects of RES in combination with other chemotherapeutic agents, such as docetaxel, paclitaxel, cisplatin, and/or doxorubicin may contribute to enhancing the anticancer properties of RES on BC cells. Although, it demonstrates promising therapeutic features, the low water solubility of RES limits its use, suggesting the use of delivery systems to improve its bioavailability. Several types of nano drug delivery systems have therefore been introduced as good candidates for RES delivery. Due to RES’s promising potential as a chemopreventive and chemotherapeutic agent for BC, this review aims to explore the anticancer mechanisms of RES using the most up to date research and addresses the effects of using nanomaterials as delivery systems to improve the anticancer properties of RES. Graphical abstract: [Figure not available: see fulltext.]. © 2022, The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Other Related Docs
11. Regulation of Cell Death Mechanisms by Melatonin: Implications in Cancer Therapy, Anti-Cancer Agents in Medicinal Chemistry (2022)
13. Circular Rnas (Circrnas) in Cancer Proliferation: Molecular Interactions and Possible Therapeutic Targets, Non-coding RNA Transcripts In Cancer Therapy: Pre-clinical And Clinical Implications (2023)
19. Prostate Cancer and Wnt/Stat3 Signaling, Prostate Cancer: Molecular Events and Therapeutic Modalities (2024)
23. Resveratrol As an Enhancer of Apoptosis in Cancer: A Mechanistic Review, Anti-Cancer Agents in Medicinal Chemistry (2021)
27. Apigenin in Cancer Therapy: Prevention of Genomic Instability and Anticancer Mechanisms, Clinical and Experimental Pharmacology and Physiology (2023)
41. Peptide-Functionalized Polymeric Nanoparticles for Delivery of Curcumin to Cancer Cells, Journal of Drug Delivery Science and Technology (2024)
50. Non-Coding Rnas and Brain Tumors: Insights Into Their Roles in Apoptosis, Frontiers in Cell and Developmental Biology (2022)